Dorien Brouwer

107 Health education in patients with recent stroke or transient ischemic attack PART 2 76. Meischke H, Ho MT, Eisenberg MS, Schaeffer SM, Larsen MP. Reasons patients with chest pain delay or do not call 911. Ann Emerg Med 1995; 25:193–7. 77. Luepker RV, Raczynski JM, Osganian S et al. Effect of a community intervention on patient delay and emergency medical service use in acute coronary heart disease: The Rapid Early Action for Coronary Treatment (REACT) trial. JAMA 2000; 284:60–7. 78. Dracup K, McKinley S, Riegel B et al. A randomized clinical trial to reduce patient prehospital delay to treatment in acute coronary syndrome. Circ Cardiovasc Qual Outcomes 2009; 2:524–32. 79. Kotseva K, Wood D, De Backer G et al. EUROASPIRE III: a survey on the lifestyle, risk factors and use of cardioprotective drug therapies in coronary patients from 22 European countries. [Article]. Eur J Cardiovas Prev Rehabil 2009; 16:121–37. 80. Giannuzzi P, Temporelli PL,Marchioli R et al. Global secondary prevention strategies to limit event recurrence after myocardial infarction: results of the GOSPEL Study, a multicenter, randomized controlled trial from the Italian cardiac rehabilitation network. Arch Intern Med 2008; 168:2194– 204. 81. Wood DA, Kotseva K, Connolly S et al. Nurse-coordinated multidisciplinary, family-based cardiovascular disease prevention programme (EUROACTION) for patients with coronary heart disease and asymptomatic individuals at high risk of cardiovascular disease: a paired, cluster- randomised controlled trial. Lancet 2008; 371:1999–2012. 82. Harmsen P, Lappas G, Rosengren A,Wilhelmsen L. Long-term risk factors for stroke: twenty-eight years of follow-up of 7457 middle-aged men in Goteborg, Sweden. Stroke 2006; 37:1663–7. 83. van Wijk I, Kappelle LJ, van Gijn J et al. Long-term survival and vascular event risk after transient ischemic attack or minor ischemic stroke: a cohort study. Lancet 2005; 365:2098–104. 84. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 2002; 360:7–22. 85. Amarenco P, Goldstein LB, Szarek M et al. Effects of intense low-density lipoprotein cholesterol reduction in patients with stroke or transient ischemic attack: the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trial. Stroke 2007; 38:3198–204. 86. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure- lowering regimen among 6,105 individuals with previous stroke or transient ischemic attack. Lancet 2001; 358:1033–41.